Study of NPO-13 During Colonoscopy

Summary

This study will investigate the safety, efficacy and dose-response of NPO-13 in subjects with moderate to severe colonic spasm during colonoscopy. An intraluminal spraying of NPO-13 dosed up to twice into ascending or sigmoid colon. The colonic spasm will be assessed by an independent committee using recorded video images. The study consists of a screening visit window, 1-day treatment phase and 1-week follow-up phase.

Timeline

Start

2019-08-26

Primary completion

2020-03-26

Completion

2020-03-26

Drugs

Indications